Abstract Emerging evidence suggests that dietary phytochemicals, in particular flavonoids, may exert beneficial effects in the central nervous system by protecting neurons against stress-induced injury, by suppressing neuroinflammation and by promoting neurocognitive performance, through changes in synaptic plasticity. It is likely that flavonoids exert such effects in neurons, through selective actions on different components within a number of protein kinase and lipid kinase signalling cascades, such as phosphatidylinositol-3 kinase (PI3K)/Akt, protein kinase C and mitogen-activated protein kinase. This review details the potential inhibitory or stimulatory actions of flavonoids within these pathways, and describes how such interactions are likely to affect cellular function through changes in the activation state of target molecules and/or by modulating gene expression. Although, precise sites of action are presently unknown, their abilities to: (1) bind to ATP binding sites on enzymes and receptors; (2) modulate the activity of kinases directly; (3) affect the function of important phosphatases; (4) preserve neuronal Ca 2+ homeostasis; and (5) modulate signalling cascades lying downstream of kinases, are explored. Future research directions are outlined in relation to their precise site(s) of action within the signalling pathways and the sequence of events that allow them to regulate neuronal function in the central nervous system.
Abstract Emerging evidence suggests that dietary phytochemicals, in particular flavonoids, may exert beneficial effects in the central nervous system by protecting neurons against stress-induced injury, by suppressing neuroinflammation and by promoting neurocognitive performance, through changes in synaptic plasticity. It is likely that flavonoids exert such effects in neurons, through selective actions on different components within a number of protein kinase and lipid kinase signalling cascades, such as phosphatidylinositol-3 kinase (PI3K)/Akt, protein kinase C and mitogen-activated protein kinase. This review details the potential inhibitory or stimulatory actions of flavonoids within these pathways, and describes how such interactions are likely to affect cellular function through changes in the activation state of target molecules and/or by modulating gene expression. Although, precise sites of action are presently unknown, their abilities to: (1) bind to ATP binding sites on enzymes and receptors; (2) modulate the activity of kinases directly; (3) affect the function of important phosphatases; (4) preserve neuronal Ca 2+ homeostasis; and (5) modulate signalling cascades lying downstream of kinases, are explored. Future research directions are outlined in relation to their precise site(s) of action within the signalling pathways and the sequence of events that allow them to regulate neuronal function in the central nervous system. Recently, there has been intense interest in the potential of flavonoids to modulate neuronal function and prevent agerelated neurodegeneration. Dietary supplementation studies, in humans and animals, using flavonoid-rich plant or food extracts have highlighted their potential to influence cognition and learning [60, 70, 95, 175, 183, 194, 197] , presumably by protecting vulnerable neurons, enhancing existing neuronal function or by stimulating neuronal regeneration. Their neuroprotective potential has been shown in both oxidative stress- [77] and Ab-induced-neuronal death models [109] . Evidence also supports the beneficial and neuromodulatory effects of flavonoid-rich ginkgo biloba extracts, particularly in connection with agerelated dementias and Alzheimer's disease [14, 109, 203] . Furthermore, the citrus flavanone, tangeretin, has been observed to maintain nigrostriatal integrity and functionality following lesioning with 6-hydroxydopamine, suggesting that it may serve as a potential neuroprotective agent against the underlying pathology associated with Parkinson's disease [42] . The exact mechanisms by which flavonoids might exert such effects are not fully understood, although evidence from cell studies suggests that flavonoids express a wide variety of cellular actions and may influence neuronal function via the modulation of critical neuronal signalling pathways. Flavonoids comprise the most common group of polyphenolic compounds in the human diet and are found ubiquitously in plants. Major dietary sources of flavonoids include fruits, vegetables, tea, wine, cereals and fruit juices (reviewed in [111] ). Flavonoids consist of two aromatic carbon rings: benzopyran (A and C rings) and a benzene (B ring) ( Fig. 1 ) and may be divided in six subgroups based on the degree of the oxidation of the C-ring, the hydroxylation pattern of the ring structure and the substitution of the 3-position. The main dietary groups of flavonoids are (1) flavonols (e.g. kaempferol, quercetin), which are found in onions, leeks, broccoli, (2) flavones (e.g. apigenin, luteolin), which are found in parsley and celery, (3) isoflavones (e.g. daidzein, genistein), which are mainly found in soy and soy products, (4) flavanones (e.g. hesperetin, naringenin), which are mainly found in citrus fruit and tomatoes, (5) flavanols [e.g. catechin, epicatechin, epigallocatechin, epigallocatechin gallate (EGCG)], which are abundant in green tea, red wine, chocolate, and (6) anthocyanidins (e.g. pelargonidin, cyanidin, malvidin), whose sources include red wine and berry fruits. Further information regarding the structure and classes of flavonoids may be found in the thorough review by Manach et al. [111] .
Historically, the biological actions of flavonoids have been attributed to their antioxidant properties, either through their reducing capacities per se or through their influences on the intracellular redox status [139, 140] . However, it has been speculated that their classical hydrogen donating antioxidant activity is not the explanation for the bioactivity of flavonoids in vivo. Indeed, it has become evident that flavonoids are more likely to exert their neuroprotective actions by (1) the modulation of intracellular signalling cascades which control neuronal survival, death and differentiation; (2) affecting gene expression and (3) interactions with mitochondria [148, 159, 185] . This review will highlight some of the interactions of flavonoids with major neuronal intracellular signalling pathways, in particular those that are vital in determining neuronal death, survival, differentiation and proliferation. Although, there have been a huge number of investigations into the actions of flavonoids within signalling pathways, the aim of this review will be to highlight the potential mechanisms by which flavonoids interact within neuronal signalling cascades.
Flavonoid metabolism and access to the brain
Flavonoids display potent antioxidant capacity in vitro [138] [139] [140] . However, during absorption flavonoids are extensively metabolised resulting in a significant alteration in their redox potentials. It has become clear that the bioactive forms of flavonoids in vivo are not those forms found in plants. For example, the majority of flavonoid glycosides, and in some instances the aglycones, present in plant-derived foods, are extensively conjugated and metabolised during absorption (reviewed in [47, 51, 162, 163, 180] ). In particular, there is much evidence for the extensive phase I de-glycosylation and phase II metabolism of the resulting aglycones to glucuronides, sulphates and O-methylated forms during transfer across the small intestine [157, 162] and then again in the liver. Further transformation has been reported in the colon where the enzymes of the gut microflora degrade flavonoids to simple phenolic acids [146] . In addition, flavonoids may undergo at least three types of intracellular metabolism: (1) Oxidative metabolism, (2) P450-related metabolism and (3) conjugation with thiols, particularly GSH [158, 160] . Circulating metabolites of flavonoids, such as glucuronides, sulphates and conjugated O-methylated forms, or intracellular metabolites like flavonoid-GSH adducts, have greatly reduced antioxidant potential [160] . Indeed, studies have indicated that although such conjugates and metabolites may participate directly in plasma antioxidant reactions and in scavenging reactive oxygen and nitrogen species in the circulation, their effectiveness is reduced relative to their parent aglycones [41, 122, 152, 170, 189] .
In order to understand whether flavonoids and their metabolic derivatives are capable of direct neuroprotective effects, it is crucial to ascertain whether they are able to access the central nervous system. In order for flavonoids to enter into the brain, they must first cross the blood brain barrier (BBB). The function of the BBB includes protection of the brain from xenobiotics and the general maintenance of the brain's microenvironment [2, 193] . Studies by Youdim et al. indicated that certain flavonoids were able to penetrate the BBB in relevant in vitro and in situ models [193, 195, 196] . In these studies, the flavanones, hesperetin, naringenin and their relevant in vivo metabolites, as well as some dietary anthocyanins, cyanidin-3-rutinoside and pelargonidin-3-glucoside, were able to traverse the BBB. Furthermore, it was demonstrated that the uptake of the relatively lipophilic flavanones, naringenin and hesperetin, was much greater than for other flavonoids, such as epicatechin, epicatechin metabolites, anthocyanins and their glucuronidated metabolites, which are more polar in nature. This study suggested that the potential for flavonoid penetration is dependent on compound lipophilicity [193] . Accordingly, it is plausible that the uptake of the less polar methylated metabolites, such as the methylated epicatechin metabolites (formed in the small intestine and liver), may be greater than the parent aglycone. For the same reason, the more polar flavonoid glucuronidated metabolites, which seem to have low BBB permeability values [193] , may not be able to access the brain. However, evidence exists to suggest that certain drug glucuronides may cross the BBB [1] and exert pharmacological effects [94, 164] , suggesting that there may be a specific uptake mechanism for glucuronides in vivo. It has also been suggested that apart from the components' lipophilicity, the ability of flavonoids to enter the brain may be influenced by their interactions with specific efflux transporters expressed in Fig. 1 The structures of the five main classes of flavonoids. The major differences between the individual groups reside in the hydroxylation pattern of the ring-structure, the degree of saturation of the C-ring and the substitution of the 3-position the BBB. One such transporter is P-glycoprotein [195] , which plays an important role in drug absorption and brain uptake [107] . In the study conducted by Youdim et al. [195] , the differences between naringenin and quercetin flux into the brain in situ was attributed not only to their differences in lipophilicity, but also to their ability to act as efflux transporter substrates. There is also evidence from animal feeding studies to suggest that flavonoids may access the brain. The tea flavanol EGCG has been reported to access the brain after oral administration to mice [166] . Furthermore, oral ingestion of pure epicatechin resulted in the detection of epicatechin glucuronide and 3 0 -O-methyl-epicatechin glucuronide in rat brain tissue [3] . Anthocyanidins have also been detected in the brain after oral administration [53, 168] , with several anthocyanidins being identified in different regions of rat brain after the animals were fed with blueberry [12] . Such flavonoid localisation has been correlated with increased cognitive performance, suggesting a central neuroprotective role of these components.
It is clear that the concentrations of flavonoids and their metabolite forms accumulated in vivo, for example in the plasma or in organs such as the brain [3] are lower (high nM, low lM) than those recorded for small molecule antioxidant nutrients such as ascorbic acid and a-tocopherol [67] . In addition, these in vivo forms will mainly be metabolites possessing lower antioxidant potential relevant to parent compounds. Therefore, the beneficial effects of flavonoid metabolites in vivo are unlikely to result by their ability to out-compete antioxidants such as ascorbate, which are present at higher concentrations (high lM to mM). For example, flavonoids have been shown to protect neurons against oxidative stress more effectively than ascorbate even when the latter was used at tenfold higher concentrations [150] , which supports a non-antioxidant mechanism of action. If such an antioxidant mechanism is unlikely in vivo, there must be other potential routes by which they exert beneficial effects at the cellular and tissue level. Over the last 5-10 years evidence has accumulated to suggest that the cellular effects of flavonoids may be mediated by their interactions with specific proteins central to intracellular signalling cascades [148] . In the next section we highlight the potential for these polyphenols and their metabolites to interact at various points within the mitogen activated protein kinase (MAP kinase) signalling pathway and the phosphoinositide 3-kinase (PI3 kinase/Akt) signalling cascade.
Flavonoid interactions with neuronal signalling cascades
Flavonoids have been shown to exert modulatory effects in neurons through selective actions at different components of a number of protein kinase and lipid kinase signalling cascades, such as the PI3 kinase (PI3K)/Akt, tyrosine kinase, protein kinase C (PKC) and mitogen-activated protein kinase (MAP kinase) signalling pathways [7, 61, 93, 116, 149, 159, 178] (Fig. 2) . Inhibitory or stimulatory actions at these pathways are likely to profoundly affect cellular function by altering the phosphorylation state of target molecules and/or by modulating gene expression. Although selective inhibitory actions at these kinase cascades may be beneficial in cancer, proliferative diseases, inflammation and neurodegeneration they could be detrimental during development particularly in the immature nervous system when protein and lipid kinase signalling regulates survival, synaptogenesis and neurite outgrowth. In the mature brain, post-mitotic neurones utilise MAP kinase and PI3K cascades in the regulation of key functions such as synaptic plasticity and memory formation [106, 167] (Fig. 2) , thus flavonoid interactions within these pathways could have unpredictable outcomes and will be dependent both on the cell type and disease studied.
Flavonoids have the potential to bind to the ATP-binding sites of a large number of proteins [38] including, mitochondrial ATPase [50] , calcium plasma membrane ATPase [13] , protein kinase A [136] , protein kinase C [61, 81, 101, 142, 176] and topoisomerase [18] . In addition, interactions with the benzodiazepine binding sites of GABA-A receptors and with adenosine receptors [48, 117] have been reported. For example, the stilbene resveratrol and the citrus flavanones, hesperetin and naringenin, have been reported to have inhibitory activity at a number of protein kinases Fig. 2 Overview of MAP kinase and Akt/PKB signalling cascades in neurons. Flavonoid-induced activation of ERK1/2 or PI3K/Akt pathways acts to stimulate neuronal survival and/or enhance synaptic plasticity and long-term potentiation relevant to the laying down of memory. In addition, inhibitory actions within JNK and p38 pathways are likely to be neuroprotective in the presence of stress [56, 73, 154] . This inhibition is mediated via the binding of the polyphenols to the ATP binding site, presumably causing three-dimensional structural changes in the kinase leading to its inactivity. They may also interact directly with mitochondria, for example, by modulating the mitochondrial transition pore (mPT), which controls cytochrome c release during apoptosis [65, 169] , or by modulating other mitochondrial associated pro-apoptotic factors such as DIABLO/smac [64, 165] . Potential interactions with the mPT are especially interesting, as the transition pore possesses a benzodiazepine-binding site where flavonoids may bind [48, 117] and influence pore opening and cytochrome c release during apoptosis.
Flavonoids may also be capable of modulating glutamate excitotoxicity via direct scavenging of ROS or by the modulation of calcium influx. Abnormal influx of Ca 2+ through AMPA-type glutamate receptors has been strongly implicated in neuronal death associated with a number of brain disorders through activation of Ca 2+ -dependent proteases, phospholipases and stress-activated kinases. Flavonoids may be capable of rendering heteromeric AMPA receptor assemblies Ca 2+ -impermeable by up-regulating GluR2 subunit expression [147] . Alternatively, flavonoids and their metabolites may prevent neuronal injury by scavenging of reactive intermediates such as superoxide and peroxynitrite derived from calcium mediated activation of xanthine oxidase and nitric oxide synthase, respectively. Lastly, modulation of signalling pathways and inhibition of calcium-activated kinases may also act to prevent excitotoxic death in neurons.
MAP kinase signalling cascade
Mitogen-activated protein kinases (MAPK) belong to the super-family of serine/threonine kinases and play a central role in transducing various extracellular signals into intracellular responses [36, 63] . MAPK cascades are organised into three main levels of regulation: (1) a MAP kinase kinase kinase (MAPKKK), which phosphorylates and activates (2) a MAP kinase kinase (MAPKK), which in turn, phosphorylates and activates (3) a MAPK [36, 114] . The best characterised MAPK pathways are the mitogenic extracellular signal-regulated protein kinase (ERK) pathway (Fig. 3) and the stress activated, c-Jun N-terminal kinase (JNK) (Fig. 4) and p38 (Fig. 5) cascades. Once activated, ERK, JNK and p38 phosphorylate a number of cytosolic proteins and transcription factors resulting in the enhancement of their transcriptional activities and activation of dependent genes [84] .
ERK and JNK are generally considered as having opposing actions, in particular in neuronal apoptosis [188] . ERK1/2 are usually associated with pro-survival signalling [11, 19, 83] through mechanisms that may involve activation of the cAMP response element binding protein (CREB) [19, 39] (Fig. 3) , the up-regulation of the antiapoptotic protein Bcl-2 and non-transcriptional inhibition of BAD [19, 83] . On the other hand, JNK has been strongly linked to transcription-dependent apoptotic signalling [118, 198] , possibly through the activation of c-Jun [15] and other AP-1 proteins including JunB, JunD and ATF-2 [46] (Fig. 4) . Many investigations have indicated that flavonoids and their metabolites may interact selectively within the MAPK signalling pathways [92, 93] . The potential modulation of MAPK signalling by flavonoids is significant as ERK1/2 and c-Jun amino-terminal kinase are involved in growth factor induced mitogenesis, differentiation, apoptosis and various forms of cellular plasticity [32, 33, 71, 118, 198] .
Oxidative stress also has a diverse effect on the MAPK cascade [17, 172, 174] . Changes in the cellular redox status may result in the activation of pro-apoptotic signalling proteins such as JNK [46, 129, 141, 145, 148] , which may initiate apoptotic mechanisms within cells [96] (Fig. 4) . Additionally, oxidative stress may affect mitochondria by influencing the mitochondrial transition pore (mPT) and/or release of cytochrome c [88, 102] . There is strong evidence linking the activation of JNK to neuronal death in response to a wide array of pro-apoptotic stimuli both in developmental and degenerative death signalling [46, 118] . In the context of oxidative insults in neurons, JNK has been shown to be activated by dopamine [110] , by 4-HNE [24, 132, 155] , through reduced expression of SOD1 [113] , by hydrogen peroxide [39] and by oxLDL [149] .
Extracellular signal-regulated protein kinase pathway
The ERK pathway is activated when Ras recruits c-Raf (a MAPKKK) to the membrane, resulting in its activation. Activated Raf then phosphorylates and activates MEK1/2 (MAPKK), which directly activates ERK through dual phosphorylation on threonine 202 and tyrosine 204 residues within the tripeptide motif TEY (Fig. 3) . The ERK pathway is very responsive to growth factors and signals from certain G protein-coupled receptors and protein kinase C and two major isoforms of ERK, p44 (ERK1) and p42 (ERK2) have been identified [21] . Although most investigations have centred on the potential of flavonoids to modulate the phosphorylation state of ERK1/2 [74, 108, 148, 149, 159] , it is highly likely that their actions on this MAPK isoform result from effects on upstream kinases, such as MEK1 and MEK2, and potentially membrane receptors [148] . This appears likely as flavonoids have close structural homology to specific inhibitors of ERK signalling, such as PD98059 (2 0 -amino-3 0 -methoxyflavone) (Fig. 6 ). PD98059 is a flavone that has been shown to act in vivo as a highly selective non-competitive inhibitor of MEK1 activation and the MAP kinase cascade [9, 52, 98, 130] . PD98059 acts via its ability to bind to the inactive forms of MEK so preventing its activation by upstream activators such as c-Raf [9] (Fig. 3) . This raises the possibility that flavonoids, and their metabolites, may also act on this pathway in a similar manner. In support of this, the flavonol quercetin, and to a lesser extent its O-methylated metabolites have been shown to induce neuronal apoptosis via a mechanism involving the inhibition of ERK, rather than by induction of pro-apoptotic signalling through JNK Fig. 4 [159] . The potent inhibition of ERK activation, and indeed Akt/PKB phosphorylation, was accompanied by activation of BAD and a subsequent strong activation of caspase-3.
There is increasing evidence that neuroinflammatory processes contribute to the progressive neuronal damage observed in neurodegenerative disorders such as AD [128] and PD [90, 177] , and also with neuronal injury associated with stroke [10] . Central to neuroinflammation is the generation of nitric oxide (NO • ) via increases in the expression of the inducible isoform of nitric oxide synthase (iNOS) in glial cells. Crucially the transcriptional regulation of iNOS in activated glial cells is dependent on signalling through the MAPK pathway, specifically through activation of ERK1/2 [16, 55, 112] . The MEK inhibitor PD98059 has been shown to effectively block iNOS expression and generation of NO
• [16] , suggesting that flavonoids may also be capable of exerting antiinflammatory actions via inhibitory actions on MEK1 within the ERK signalling pathway. Thus far, studies have indicated that flavanols [72, 105] , flavones [34, 87, 99, 151, 186] , and flavonols [35] are all capable of inhibiting the release of NO
• by activated microglia via the down-regulation of iNOS gene expression. However, it is not known if such effects are mediated by changes in signalling through ERK, or any other MAPK. Whether inhibition of MAPK signalling by flavonoids plays a role in the observed anti-neuroinflammatory effects requires further investigation.
Certain flavonoids have also been observed to exert a stimulatory effect on ERK1/2. For example, the flavan-3-ol, (-)-epicatechin, and one of its metabolites, 3 0 -O-methyl-(-)-epicatechin, have been shown to stimulate phosphorylation of ERK1/2 and the downstream transcription factor CREB at physiologically relevant concentrations [147] . Interestingly, this activation of the ERK pathway was no longer apparent at higher concentrations suggesting that effects on this pathway are concentration specific. Furthermore, stimulation of the ERK1/2 and CREB was not observed with (-)-epicatechin-5-O-b-D-glucuronide suggesting that effects on the ERK pathway may be dependent on cell or membrane permeability, as has been previously reported [160] . In support of these observations, the protective action of another flavanol, EGCG, against 6-hydroxy dopamine toxicity and serum deprivation has been shown to involve the restoration of both protein kinase C and ERK1/2 activities [104, 137] . One explanation for the concentration-specific regulation of the ERK pathway, and indeed other MAP kinase cascades (JNK and p38), may be related to the ability of flavonoids to exert high affinity receptor agonist-like actions at low concentrations and direct enzyme inhibition at higher concentrations [7, 179] , or by inducing receptor desensitization. The identity of the primary flavonoid interacting sites in neurons is unknown and could be either at the cell surface or intracellular, although the ERK and PI3K dependence to CREB phosphorylation is very similar to ionotropic receptor signalling [133] . Receptors reported to act as flavonoid-binding sites, that are present in cortical neurons, are adenosine [79] and GABA A receptors [4, 80] . However, a specific plasma membrane binding site for polyphenols has recently been described in rat brain [69] . In addition, monomeric and dimeric flavanols show nanomolar affinity and efficacy at testosterone receptors [127] and resveratrol rapidly activates ERK signalling through alpha and beta oestrogen receptors [91] . Collectively, this raises the possibility that flavonoids may act on the ERK pathway via acting through steroid-like receptors in neurons to modulate ERK and CREB-mediated gene expression.
In addition to a receptor-mediated mechanism, it is equally plausibly that changes in ERK activation and related transcription factors (i.e. CREB) may result from flavonoid-induced modulation of phosphatase activity. Phosphatases act in opposition to kinases by de-phosphorylating specific kinases and in the process either activate or de-activate them. Consequently, phosphatases are integral to many signalling pathways. Because ERK and other MAPK require both Thr and Tyr phosphorylation for full activity, dual specificity phosphatases (DSPs) that de-phosphorylate both sites are uniquely positioned to regulate MAPK signal transduction cascades. At least nine DSPs, also termed MAPK phosphatases (MKPs), have been identified in mammalian cells [25] . DSPs frequently associated with ERK inactivation include MKP3, MKP4, and phosphatase of activated cells 1 (PAC1), although MKP3 (also termed PYST1) is probably the best studied and the most specific for ERK1/2 versus other MAPK [89] . The finding that multiple phosphatases inactivate the ERK pathway suggests that the duration and extent of ERK activation is controlled by a balance of the activities of upstream MAPKK, such as MEK1, and phosphatases, such MKP3. Although there has been intense interest in the ability of flavonoids to modulate kinases, thus far there is no indication that they may affect signalling pathways via a modulation of phosphatase activity. If flavonoids are capable for reacting with phosphatases, such as MKP3, then this is likely to have a dramatic effect on the activation states of important kinases like ERK1/2. Future investigations in this area should consider the potential of flavonoids to inhibit, or activate phosphatases, the concentration-dependency of these effects and the mechanism by which they do so.
Stress-activated protein kinases: c-Jun-N-terminal kinase (JNK) and p38
c-Jun-N-terminal kinase (JNK) is regulated by a variety of MAPKKK's, including MEKK1/4 and apoptosis signalrelated kinase (ASK1) [26, 76] , which is further regulated by GTPases and Rac1 [120, 121] (Fig. 4) . Unlike the ERK pathway, the JNK cascade is strongly activated by stress signals such as UV and c-radiation, oxidative stress and inflammatory cytokines [45, 75, 97, 103, 184] . JNK itself is activated by MKK4/7, a MAPKK, via dual phosphorylation within the Thr 138 -Pro-Tyr-185 motif (pTPpY) in its catalytic core. There is very strong evidence linking the activation of JNK to neuronal injury in response to a wide array of pro-apoptotic stimuli in both developmental and degenerative death signalling [45, 46, 118] . In the context of oxidative insults in neurons, JNK has been found to be activated by dopamine [110] , by 4-HNE [24, 132, 155] and through reduced expression of superoxide dismutase (SOD) 1 [113] . In addition, the activation of JNK pathway and the death of specific neuronal populations is crucial during early brain development [103] . As with the other MAP kinases, the core signalling unit is composed of a MAPKKK, typically MEKK1-4, which phosphorylate and activate MKK4-7, which then phosphorylate and activate the JNK [45, 75] . Another MAPKKK, apoptosis signal- regulating kinase 1 (ASK1), also plays an essential role in stress-induced apoptosis [76, 182] . ASK1 can be activated in response to a variety of stress-related stimuli, including oxidative stress and activates MKK4, which in turn activates JNK (Fig. 4 ) and indeed p38 (Fig. 5 ) [115] . Overexpression of ASK1 has been shown to induce the activation of both JNK and p38 and lead to apoptosis via signals involving the mitochondrial cell death pathway [76, 103] . The flavanols, epicatechin and 3 0 -O-methyl-epicatechin have been shown to protect neurons against oxidative damage via a mechanism involving the suppression of JNK, and downstream partners, c-jun and pro-caspase-3 [149, 161] . In support of these observations, the flavone, baicalein, has been shown to significantly inhibit 6-OHDAinduced JNK activation and neuronal cell death and quercetin may suppress JNK activity and apoptosis induced by hydrogen peroxide [78, 181] , 4-hydroxy-2-nonenal [173] and tumour necrosis factor-alpha (TNF-alpha) [92] . There are a number of potential sites where flavonoids may interact with the JNK pathway. For instance, flavonoidmediated inhibition of oxidative stress-induced apoptosis may occur by preventing the activation of JNK by influencing one of the many upstream MAPKKK activating proteins that transduce signals to JNK (Fig. 4) . Their ability to inhibit JNK activation may proceed via flavonoid-induced modulation of the ASK1 phosphorylation state, and its association with 14-3-3 protein, which is essential for suppression of cellular apoptosis [201] . Oxidative stress in known to regulate the activity of this MAPKKK by causing the de-phosphorylation of ASK1 at Ser 967 and its phosphorylation at Thr 845 in the activation loop, both of which are correlated with ASK1 activity and ASK1-dependent apoptosis [62, 171] . Flavonoids may modulate ASK1 activity by affecting these phosphorylation sites, or by influencing PI3K/Akt signalling, which is known to induce phosphorylation of ASK1 at Ser 83 , an event which attenuates ASK1 activity and promotes cell survival [86] .
Another potential mechanism by which flavonoids act is through the ability to preserve Ca 2+ homeostasis, thereby preventing Ca 2+ -dependent activation of JNK [45, 149] . Calcium dependent MAPK signalling has been suggested to play a role in glutamate receptor-mediated neuronal stress [133] . The influx of Ca 2+ into the cytosol from the extracellular space or from intracellular stores following stress stimuli may activate Ca 2+ /calmodulin kinases, which in turn can stimulate the activation of all three MAPK, especially JNK [190] . Alternatively, flavonoids may exert direct interactions with upstream signalling components required for the recruitment and activation of JNK in neurons. Studies have indicated that some flavonoids may be capable of exerting neuroprotective actions through an attenuation of the pro-apoptotic signalling cascade lying downstream of JNK. Phosphorylation of the AP-1 protein c-Jun on Ser-63 and Ser-73 by JNK causes increased transcriptional activity [134] , which has been linked to stress-induced apoptosis. Activated c-Jun is known to regulate the expression of pro-apoptotic genes that may activate Bax, leading to the release of cytochrome c from mitochondria, and culminating in a stimulation of caspases 9 and 3 [198] . Investigation has indicated that oxidativeinduced activation of caspase-3 in neurons is blocked by flavonoids, providing compelling evidence in support of a potent anti-apoptotic action of flavonoids in these cells [149, 150, 160] .
The p38 mitogen-activated protein kinase also plays an important role in the signal transduction of extracellular signals into the nucleus [125, 143] (Fig. 5) . Similar to the JNK pathway, p38 MAP kinase is activated by a variety of cellular stresses including osmotic shock, pro-inflammatory inflammatory cytokines, lipopolysacharides, UV light and growth factors [68, 100, 125, 135, 144] . The p38 pathway is regulated by the MKKs, MKK3 and MKK6, which in turn, are regulated by the upstream MAPKKK, MEK1/4 and ASK [125] (Fig. 5) . The activation of p38 has been shown to lead to the phosphorylation of the transcription factors ATF-2 [135] , Max [199] and MEF2 [191, 202] . Such targets, in particular ATF-2 and MEF2 are known to regulate various forms of cellular stress, including genotoxic agents, inflammatory cytokines and UV irradiation.
There are very few investigations that have addressed the ability of flavonoids to modulate neuronal signalling through the p38 pathway. However, there are some studies which suggest that flavonoids may interact within the p38 pathway in other cells types, for example in human mammary epithelial cells [59] , thus hinting that they may be able to induce neuronal effects via this pathway. The challenge now is to determine the precise site(s) of action of flavonoids within the p38 cascade and the sequence of events that allow them to regulate stress-induced neuronal death in the central nervous system. One such potential site of action may be specific redox-sensitive motifs, notably cysteine residues, similar to those reported for JNK [131] . JNK redox regulation has been proposed to proceed through its binding to redox sensitive proteins such as glutathione-S-transferase (GST) [5, 6, 123] . It has been shown that under unstressed conditions, JNK is associated with GST resulting in the inhibition of JNK activity, but that JNK dissociates from GST following UV or oxidative stress [5, 192] . Flavonoids also may act to inhibit JNK activity, and other MAPK members, via the nucleophilic addition of flavonoid o-quinones, formed from the intracellular oxidation of flavonoids [156, 158] , to these cysteine residues.
Genes Nutr (2007) 2:257-273 265 PI3 kinase signalling pathway
In addition to MAPK pathway, flavonoids have been shown to modulate signalling through the serine/threonine kinase, Akt/PKB, one of the main downstream effectors of PI3K, a pivotal kinase in neuronal survival [37, 40, 85, 119] (Fig. 7) . PI3K is a heterodimer of a catalytic subunit (p110) and a regulatory subunit (p85) [27, 31, 82] and it is thought that binding between PI3K and phospholipids is due to the ability of the regulatory subunit to interact with both the catalytic subunit and receptor tyrosine kinases. Active PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP 3 ) by phosphorylating phosphatidylinositol (PI), phosphatidylinositol-4-phosphate (PIP) and phosphatidylinositol-4,5-bisphosphate (PIP2). PIP 3 may then activate phosphoinositide-dependent protein kinase 1 (PDK1), which plays a central role in many signal transduction pathways [31, 153] , activating Akt and the PKC isoenzymes p70 S6 kinase and RSK [126] . Through its effects on these kinases, PDK1 is involved in the regulation of a wide variety of processes, including cell growth, cell proliferation, differentiation, cell cycle entry, cell migration and apoptosis [31] . One of the most important targets of PI3K and PDK1 is Akt, (also known as Protein Kinase B), as this kinase plays a critical role in controlling cellular survival and apoptosis [22, 57, 58] . Akt promotes cell survival by inhibiting apoptosis through its ability to phosphorylate and inactivate several important targets, including Bad [30] , Forkhead transcription factors [20, 23] and caspase-9 [22] (Fig. 6) . Indeed, activation of Akt/PKB in neurons has been shown to lead to an inhibition of proteins central to neuronal death machinery, such as the pro-apoptotic Bcl-2 family member, BAD [200] , and members of the caspase family [19, 85] that specifically cleave poly(ADP-ribose) polymerase [37, 85] , thus promoting cell survival. Akt is activated by phospholipid binding and activation loop phosphorylation at Thr 308 by PDK1 [8] and by phosphorylation within the carboxy terminus at Ser 473 and the activation of Akt is a pro-survival event in many cell types due to its ability to inactivate BAD via phosphorylation at Ser 136 [43, 49] . There is powerful evidence that flavonoids inhibit PI3K via direct interactions with its ATP binding site. Indeed, a number of studies have demonstrated that the structure of flavonoids determines whether or not they act as potent inhibitors of PI3K [7, 54] . One of the most selective PI3K inhibitors available, LY294002 (Fig. 5) , was modelled on the structure of quercetin [116, 178] . LY294002 and quercetin fit into the ATP binding pocket of the enzyme Fig. 7 Potential points of action of flavonoids within PI3K/Akt signalling pathway. Active PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP 3 ) which activates phosphoinositide-dependent protein kinase 1 (PDK1). PDK1 plays a central role in many signal transduction pathways, activating Akt and the PKC isoenzymes p70 S6 kinase and RSK. Through its effects on these kinases, PI3K is involved in the regulation of a wide variety of processes, including cell growth, cell proliferation, differentiation, cell cycle entry, cell migration and apoptosis. Flavonoids have been proposed to act on this pathway via direct modulation of PI3K activity via binding to its ATP binding pocket, in a similar manner to that of LY294002. Alternatively, they may act to modulate the activity of the tumour suppressor, PTEN although with surprisingly different orientations [179] . It appears that the number and substitution of hydroxyl groups on the B-ring and the degree of un-saturation of the C2-C3 bond are important determinants of this particular bioactivity. Interestingly in this regard quercetin and some of its in vivo metabolites inhibit pro-survival Akt/PKB signalling pathways [159] by a mechanism of action consistent with the flavonoids binding to and inhibiting PI3K activity. Prior to inducing measurable losses of neuronal viability, quercetin stimulates a strong inhibition of basal Akt phosphorylation at both the regulatory serine 473 and catalytic threonine 308 sites, rendering it inactive. The inhibition of Akt/PKB phosphorylation in this way may reflect potential inhibition of its upstream partner PI3K, as has previously been described [116] . If Akt/PKB inhibition is sustained, which has been reported to occur during neuronal exposure to quercetin, this leads to extensive caspase-3 activation and subsequent caspasedependent cleavage of Akt/PKB, an event that effectively turns off the major survival signal and results in the acceleration of apoptotic death [159] . However, at lower concentrations, quercetin has also been shown to trigger CREB activation in neurons indicating that exposure concentration is pivotal in determining either proapoptotic or anti-apoptotic effects [159] . Indeed, low concentrations of quercetin, may activate the MAPK pathway (ERK2, JNK1 and p38) leading to expression of survival genes (c-Fos, c-Jun) and defensive genes (Phase II detoxifying enzymes; glutathione-S-transferase, quinone reductase) resulting in survival and protective mechanisms (homeostasis response), whereas high concentrations stimulate pro-apoptotic pathways and ultimate caspase activation [93] .
Another potential mechanism by which flavonoids may modulate the PI3 kinase/Akt signalling pathway is by their ability to modulate the expression or activity of PTEN (phosphatase and tensin homologue deleted on chromosome ten), also referred to as MMAC (mutated in multiple advanced cancers) phosphatase [29, 44, 66] . PTEN is a tumour suppressor implicated in a wide variety of human cancers [28] and the main substrates of PTEN are inositol phospholipids generated by the activation of the PI3K [124] . PTEN acts a major negative regulator of the PI3K/Akt signalling pathway [28, 187] and thus a modulation of its expression or activation by flavonoids will have a profound effect of cellular function. For example, if flavonoids are capable of inhibiting PTEN in cancer cells this may lead to an increase in cancer cell proliferation and tumour growth. On the other hand, its activation in post-mitotic cells, such as neurons, may have a positive effect by increasing Akt and CREB activity leading to a promotion of neuronal survival and synaptic plasticity (Fig. 2) .
Conclusions
Emerging evidence suggests that dietary phytochemicals, in particular flavonoids, may exert beneficial effects in the CNS by protecting neurons against stress induced injury, by suppressing the activation of microglia and astrocytes, which mediate neuroinflammation, and by promoting synaptic plasticity, memory and cognitive function. Evidence supports the localization of flavonoids within the brain, thus these phytochemicals may be regarded as a potential neuroprotective, neuromodulatory or anti-neuroinflammatory agents. It appears highly likely that such beneficial properties are mediated by their abilities to interact with both protein and lipid kinase signalling cascades, rather then via their potential to act as antioxidants. The concentrations of flavonoids encountered in vivo are sufficiently high to exert pharmacological activity at receptors, kinases and transcription factors. However, precise sites of action are presently unknown. It is likely that their activity depends on their ability to: (1) bind to ATP sites on enzymes and receptors; (2) modulate the activity of kinases directly, i.e. MAPKKK, MAPKK or MAPK; (3) affect the function of important phosphatases, which act in opposition to kinases; (4) preserve Ca 2+ homeostasis, thereby preventing Ca 2+ -dependent activation of kinases in neurons; and (5) modulate signalling cascades lying downstream of kinases, i.e. transcription factor activation and binding to promoter sequences.
Another unknown factor relates to the precise cellular site of action of flavonoids. For example, does flavonoid action require cellular uptake or are they capable of mediating effects via extracellular receptor binding. Presently, there is no certainty either way, although flavonoid glucuronides, which are unable to enter cells to any significant degree, do not express cellular effects. This may suggest a requirement for cytosolic localisation, although it could equally signify that the conjugation of flavonoids with glucuronide or sulphate moieties blocks receptor binding and therefore their cellular activity. It appears likely that the inhibition of Akt is almost certainly mediated via actions at PI3K, thus requiring cellular uptake. However, actions at ERK1/2 could result from either flavonoid modulation of upstream regulatory kinases or by binding directly to receptors. The challenge now is to determine the precise site(s) of action of flavonoids within the signalling pathways and the sequence of events that allow them to regulate neuronal function in the central nervous system.
Ultimately actions within these neuronal signalling cascades may be beneficial or negative in the context of the brain. For example, whilst they may be positive in the treatment of proliferative diseases, they could be detrimental to the nervous system, at least at high concentrations, where these same pathways act to control neuronal survival and synaptic plasticity. Thus, flavonoid interactions with intracellular signalling pathways could have unpredictable outcomes and will be dependent on the cell type (i.e. neurons, astrocytes, microglia, oligodendrocytes), the disease studied and the stimulus applied. In summary, it is evident that flavonoids are potent bioactive molecules and a clear understanding of their mechanisms of action as modulators of cell signalling will be crucial in the evaluation of their potential to act as inhibitors of neurodegeneration or as modulators of brain function.
